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Mass spectrometry and 
multivariate analysis to classify 
cervical intraepithelial neoplasia 
from blood plasma: an untargeted 
lipidomic study
Ana C. O. Neves1, Camilo L. M. Morais1,2, Thais P. P. Mendes2, Boniek G. Vaz3 &  
Kássio M. G. Lima1
Cervical cancer is still an important issue of public health since it is the fourth most frequent type of 
cancer in women worldwide. Much effort has been dedicated to combating this cancer, in particular 
by the early detection of cervical pre-cancerous lesions. For this purpose, this paper reports the use 
of mass spectrometry coupled with multivariate analysis as an untargeted lipidomic approach to 
classifying 76 blood plasma samples into negative for intraepithelial lesion or malignancy (NILM, 
n = 42) and squamous intraepithelial lesion (SIL, n = 34). The crude lipid extract was directly analyzed 
with mass spectrometry for untargeted lipidomics, followed by multivariate analysis based on the 
principal component analysis (PCA) and genetic algorithm (GA) with support vector machines (SVM), 
linear (LDA) and quadratic (QDA) discriminant analysis. PCA-SVM models outperformed LDA and QDA 
results, achieving sensitivity and specificity values of 80.0% and 83.3%, respectively. Five types of lipids 
contributing to the distinction between NILM and SIL classes were identified, including prostaglandins, 
phospholipids, and sphingolipids for the former condition and Tetranor-PGFM and hydroperoxide lipid 
for the latter. These findings highlight the potentiality of using mass spectrometry associated with 
chemometrics to discriminate between healthy women and those suffering from cervical pre-cancerous 
lesions.
Nowadays cervical cancer is still an important issue of public health, being the fourth most prevalent type of 
cancer in women worldwide and accounting for an estimate of 528.000 new cases and 260.000 deaths in 2012. 
This situation is even worse in less developed regions, where the vast majority of new cases appear1. There are two 
main approaches to combat this particular type of cancer: i) screening programs (Pap smear, as the gold standard) 
and ii) more currently the human papillomavirus vaccination to protect against HPV infection. Being the most 
frequent sexually transmitted disease around the world2–4, HPV infection causes squamous intraepithelial lesions 
of the cervix (SIL) that may lead to cervical cancer. These pre-cancerous lesions are classified as low-grade squa-
mous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL)5–8 according to their 
potentiality to become cervical cancer over time, Once HPV infection can asymptomatically evolve to cervical 
cancer, it can contribute significantly to delay both diagnosis and treatment of the pre-cancerous lesions, favoring 
the development of the invasive disease9,10. In this context, new methodologies that could complement or even 
improve current protocols are of great interest in clinical and biomedical research. Aiming to enable early cancer 
diagnosis, fast, sensitive and low-cost techniques are emerging as promising alternatives for analyzing biological 
fluids such as blood serum/plasma and urine, which can be easily obtained from patients and reflect the patho-
physiological condition of the individuals11–14.
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Lipidomics is a sub-field of metabolomics that aims to detect and to quantify all lipids in biological samples15. 
In a more complete and biological definition, lipidomics is “the comprehensive understanding of the influence 
of all lipids on a biological system concerning cell signaling, membrane architecture, transcriptional and trans-
lational modulation, cell-cell and cell-protein interactions, and response to environmental changes over time”16. 
Lipids are essential biological molecules not only because they are fundamental to form the cell structure and 
serve as a major form of energy storage, but also because they participate in a variety of biological processes such 
as signaling and protein trafficking16,17. Recently, it has become clear that in many human diseases deregulated 
lipid metabolism can play an important role17,18. Thus lipidomics approaches can potentially help identify new 
mechanisms responsible for initiation of a disease process and better understand its progression to ensure that 
the correct treatment has been selected. Furthermore, lipidomics can promote early detection of diseases by 
comparing normal and diseased biological samples, considering that lipids represent key signaling molecules or 
biomarkers involved in physiological and disease processes15.
The development of soft ionization techniques has enabled mass spectrometry to become the most frequently 
used technique to study the metabolome/proteome of biological specimens, including those cancer-inflicted19–23. 
Via mass spectrometry, it is possible to either analyze all lipids of a sample or specific targeted lipid molecules. 
In untargeted lipidomics, full mass spectral profiles of lipid extracts are obtained and directly used for searching 
alterations in the lipid profile under biological perturbation and to discover novel or unexpected lipid metabo-
lites15,17. This approach is considerably useful when comparing altered and unaltered lipid profiles. However, this 
strategy demands huge computational resources to convert the high complex amount of raw mass spectral data 
into meaningful information17,24. Advances in chemometrics have boosted the application of lipidomics in several 
research fields25. Multivariate analysis is a crucial tool for extracting valuable information from mass spectral 
data, being well-established to every step of lipidomics data analysis such as preprocessing, variable selection, 
metabolic identification, and modeling25,26. Also, chemometrics tools can help overcome some common problems 
of mass spectrometry related to sensitivity and reproducibility27.
Several recent studies have demonstrated the potentiality of mass spectrometry as a lipidomic tool for cancer 
research. However, most of those applications have coupled a chromatographic method with mass spectrometry 
to facilitate biomarkers discovery, but this methodology can be time-consuming and demands many steps of sam-
ple preparation19,23,28. In addition to that, chemometric methods for classification does not seem to be as widely 
applied in lipidomics approaches as they already are in proteomic studies13,29,30. Based on that, this work aims to 
investigate the application of an untargeted mass spectrometry lipidomics approach associated with some power-
ful chemometric strategies to rapidly and sensitively classify cervical pre-cancerous lesions using lipids extracted 
from blood plasma. The performance of some classical algorithms were compared by the ability of correctly clas-
sifying samples into NILM and SIL classes, by analyzing the obtained rates of sensitivity and specificity param-
eters. The chemometric modeling was based on the principal component analysis (PCA) and genetic algorithm 
(GA) for data reduction and variable selection, respectively; associated to linear (LDA) and quadratic (QDA) 
discriminant analysis, and also to support vector machines (SVM) as classification methods. Additionally, a com-
parison with standard classification algorithms such as k-nearest neighbors algorithm (KNN) was performed. To 
the best of our knowledge, this is the first study reporting the application of these algorithms in untargeted mass 
spectral data analysis with the proposal of classifying cervical pre-cancerous lesions in blood plasma.
Results
Mass spectrometry analysis and pre-processing. In this study, 76 blood plasma samples including 42 
of NILM class and 34 of SIL class were subjected to lipid extraction and directly analyzed by mass spectrometry. 
Figure 1A and B present the mean raw spectra of NILM and SIL samples, respectively, in the m/z range of 200 to 
1200.
To obtain meaningful information from the untargeted lipidomic data, several strategies of multivariate anal-
ysis were applied. Therefore, by using a laboratory-made routine that creates a single m/z vector common for all 
samples, all spectra were bunched into a matrix of dimension 76 × 16540 in which rows represented the 76 sam-
ples and the columns the 16540 variables (intensities of m/z 200–1200). Besides that, the dataset was normalized 
for the sum of the square of each spectrum to equals 1. Due to the high dimensionality of the matrix, a step of 
data compression was needed to improve computational analysis and to ensure an easier chemical interpretation. 
Thus, the algorithm of regions of interest (ROI) was applied to search and select only m/z features whose intensity 
were higher than a threshold of 3% of the higher intensity value, reducing the matrix dimension to 76 × 278. 
The mean spectra of NILM and SIL samples after normalization and peak selection are shown in Fig. 1C and D, 
respectively.
Identification of lipids. The difference between the mean spectrum of NILM and SIL after normalization 
and data reduction is presented in Fig. 2. The negative signal implies that this specific m/z is more intense in 
the SIL class. Table 1 presents the main chemical information associated with the findings of Fig. 2 for mass 
spectrometry analysis of blood samples from both NILM and SIL patients groups. The chemical structures were 
proposed based on Lipid Maps Lipidomic Gateway database, and the software Xcalibur provided the errors. Five 
lipids were found to contribute to the distinction between NILM and SIL classes. Prostaglandins, phospholipids, 
and sphingolipids were associated with the NILM condition, while Tetranor-PGFM and a hydroperoxide lipid 
were related to the SIL class.
PCA analysis. The pre-processed matrix (76 × 278) was the dataset used in all chemometric approaches. At 
first, an unsupervised analysis was carried out with PCA looking for trends or natural clustering behavior due to 
the chemical information related to the spectral signals among the samples studied. The first three principal com-
ponents (PC) accounted for 64.8% of the explained variance and the scores plot for PC1 versus PC2 is illustrated 
www.nature.com/scientificreports/
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Figure 1. Mass spectra of metabolites extracted from blood plasma. (A) Mean spectrum of 42 NILM samples 
before pre-processing. (B) Mean spectrum of 34 SIL samples before preprocessing. (C) Mean spectrum of 42 
NILM samples after pre-processing. (D) Mean spectrum of 34 SIL samples after preprocessing.
Figure 2. Difference between mean spectra of NILM and SIL classes.
m/z Errora Molecular formula Possible lipid Class Sample
331.177 1.540 C16H27O7 Tetranor-PGFM FAb SIL
369.227 0.853 C20H33O6 PG FAb NILM
397.258 −0.643 C22H37O6 HEFAD FAb SIL
680.450 0.490 C34H67O10NP GPS GPLc NILM
780.526 −1.249 C40H78O11NS (3′-sulfo)Galβ-Cer SPLd NILM
Table 1. Main chemical information associated with differentiation of NILM and SIL stages obtained from 
mass spectrometry analysis coupled to multivariate analysis as an untargeted lipidomic approach. aError in 
ppm; bFA = Fatty acyls; cGPL = Glycerophospholipids; dSPL = sphingolipids.
www.nature.com/scientificreports/
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by Fig. 3. It is possible to observe the presence of three major clusters. NILM and SIL are grouped together with 
no clear separation between the classes when the PC1 and PC2 area analyzed. This indicates the necessity of using 
more PCs for class differentiation.
Multivariate supervised classification. Based on the results from PCA analysis, LDA, QDA, and SVM 
methods were applied to build classification models by using either the scores from PCA or the selected variables 
by GA. Table 2 presents the values of sensitivity and specificity obtained for LDA and QDA models calculated 
using the prediction samples. With poor correct classification rates, the ability to discriminate samples between 
NILM and SIL classes was not satisfactory for all LDA and QDA models. PCA-LDA/QDA (using the scores 
of the first ten principal components) provided the worst results where the sensitivity values varied from 0 to 
60%. GA-LDA selected 22 m/z features to build a classification model that achieved better indexes of specificity 
and specificity than PCA-LDA. However, these values were lower than expected. On the other hand, GA-QDA 
selected only a small group of 15 spectral variables that did not represent properly the chemical information cor-
responding to the variation between the classes to correctly discriminate samples. This can be demonstrated by 
GA-QDA low rate of sensitivity.
Comparing these algorithms with KNN, the GA-LDA and GA-QDA had a similar performance. In terms of 
sensitivity, PCA-LDA, GA-LDA and KNN had the highest values (60.0%); and in terms of specificity the best was 
the GA-QDA (83.3%).
Table 3 presents the results achieved by the SVM models for discriminating samples into NILM and SIL 
classes. Sensitivity varied from 0 to 80% and specificity was better ranging from 16.6 to 100%.
Five different Kernels were tested aiming to choose the optimal function for this study: linear (L), quad-
ratic (Q), 3rd order polynomial (P), radial basis function (RBF) and multilayer perceptron (MLP). In the same 
way as for the discriminant analysis, SVM classifiers were applied using the scores from PCA (of the first ten 
principal components) and the selected variables from GA. Sensitivity and specificity values obtained for all 
five GA-SVM-based models were unsatisfactory in the classification of NILM and SIL samples correctly. In all 
SVM models, GA selected a set of 14 spectral variables. On the other hand, PCA-SVM-based models consider-
ably improved results, except for PCA-SVM-L and PCA-SVM-MLP that poorly separated the classes. Although 
PCA-SVM-Q poorly classified the NILM samples (with specificity of 50%), this model provided a satisfactory 
classification for samples belonging to SIL class, with sensitivity of 80%. The best performance that accurately 
classified samples into NILM and SIL was achieved by the models of PCA-SVM-P and PCA-SVM-RBF. These 
models were able to overcome the natural complexity of the data to provide sensitivity and specificity values 
of 80.0% and 83.3%, respectively. Comparing with SVM-RBF alone, the use of feature selection and extraction 
methods combined with SVM improved significantly the sensitivity.
The values of area under the curve (AUC) and F-Score for all models are shown in Table 4. For calcula-
tion, only the SVM models using RBF kernel function were considered. Among the LDA-based algorithms, 
Figure 3. PCA scores plot for NILM (red diamonds) and SIL (gray circles) samples.
Algorithm Sensitivity (%) Specificity (%)
PCA-LDA 60.0 33.3
GA-LDA 60.0 50.0
PCA-QDA 0 100
GA-QDA 40.0 83.3
KNN 60.0 66.7
Table 2. Results (sensitivity and specificity) of prediction samples for classifying NILM vs. SIL by PCA-LDA/
QDA, GA-LDA/QDA and KNN.
www.nature.com/scientificreports/
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the GA-LDA had the largest AUC (0.763) and F-score (0.545); and among the QDA-based algorithms, the 
GA-QDA was the best (AUC = 0.646 and F-score = 0.540). KNN had a performance comparable with GA-LDA 
and GA-QDA, having an AUC and F-score of 0.633 and 0.632, respectively. On the other hand, SVM-RBF and 
PCA-QDA alone had the worst performance, with an F-score of 0; therefore, no accuracy.
The algorithm with larger AUC and F-Score was the PCA-SVM-RBF, with values of 0.817 and 0.816, respec-
tively. This confirms that PCA-SVM-RBF is the best model, having the highest probability of correctly classify a 
randomly positive sample and also the most accurate one.
Figure 4 shows the loadings of PC1, PC2 and PC3 for the PCA-SVM-RBF model.
Taking into account that the coefficients can be understood as the influence of the variables (m/z features) for 
the PCA-SVM-RBF model performance, for the three principal components the most important variables for 
class differentiation are present in the region around m/z 200 to 450 as also, but less intensely, in the range of m/z 
700 to 800. These loadings are consistent with the regions that have the highest concentration of m/z signals for 
all samples, which consequently matches the region where the main spectral differences between NILM and SIL 
samples are found.
Algorithm Sensitivity (%) Specificity (%)
PCA-SVM-L 60.0 33.3
PCA-SVM-Q 80.0 50.0
PCA-SVM-P 80.0 83.3
PCA-SVM-RBF 80.0 83.3
PCA-SVM-MLP 20.0 16.7
GA-SVM-L 80.0 50.0
GA-SVM-Q 80.0 16.7
GA-SVM-P 40.0 66.7
GA-SVM-RBF 40.0 66.7
GA-SVM-MLP 60.0 33.3
SVM-RBF 0 100
Table 3. Sensitivity and specificity of prediction samples for classifying NILM vs. SIL by PCA-SVM and GA-
SVM based models. Five different kernels were applied: linear (L), quadratic (Q), 3rd order polynomial (P), 
radial basis function (RBF) and multilayer perceptron (MLP).
Algorithm AUC F-score
PCA-LDA 0.536 0.428
GA-LDA 0.763 0.545
PCA-QDA 0.500 0
GA-QDA 0.646 0.540
PCA-SVM-RBF 0.817 0.816
GA-SVM-RBF 0.536 0.500
KNN 0.633 0.632
SVM-RBF 0.500 0
Table 4. Area under the curve (AUC) and F-Score.
Figure 4. PCA-SVM-RBF loadings on PC1 (blue), PC2 (red) and PC3 (green).
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Discussion
Considering that lipids play an important role in metabolism, either in physiological or disease condition, an 
untargeted metabolomic approach was applied to classify samples according to spectral changes that could be 
attributed to the pathophysiological condition of the individuals. From Figs 1 and 2, it is possible to note that the 
majority of the signals are at low m/z range for both classes, giving them high spectral similarity, what makes it 
difficult to identify the classes only visually. There are only smooth differences when comparing the two classes, 
once again reinforcing the use of multivariate analysis to discriminate NILM and SIL samples. Since mass spec-
trometry experiments were performed without the assistance of a chromatographic separation technique and due 
the inherent ionization suppression events observed on ESI, it was not possible to characterize a high number of 
chemical species in both NILM and SIL classes within acceptable errors.
The peak at m/z 331.177 was attributed to the prostaglandin tetranor-PGFM, a metabolite of the PGF2α31 asso-
ciated with acute inflammation conditions32,33. The signal at m/z 369.227 can be related to several prostaglandin 
metabolites (PGM) such as PGG2, 6-keto PGE1, 20-hydroxy-PGE2, among others. Furthermore, this m/z feature 
is also correlated to Tromboxane B2 and B3 as well as other eicosanoic acid derivatives. There are hundreds of dis-
tinct arachidonic acid (as well as other fatty acids) derivatives described and properly characterized as eicosanoids 
that play relevant roles as bioactive signaling lipids, including regulation of several homeostatic and inflammatory 
processes34. The peak at m/z 397.258 is supposedly associated with a hydroperoxide epidioxide fatty acid deriva-
tive (HEFAD). Natural oxidation of lipids has a relevant role in many biological processes, including those associ-
ated with the development of diseases such as cancer35. In fact, the literature reports lipid hydroperoxides as major 
primary products and able to undergo several secondary reactions, including their role as substrates in enzymatic 
reactions36. The peak at m/z 680.455 may be correlated to a serine-based glycerophospholipid (GPS). In fact, it 
is well established that phospholipids play a crucial role in cell structure as main constituents of the membranes 
among other primordial functions and applications37. Lastly, the signal at m/z 780.526 is related to (3′-sulfo)
Galβ-Cer, an sphingolipid of the sulfatides subclass. Sulfatides are found in several parts of the human body and 
comprehend multifunctional chemical species that play an important role in many biological functions, including 
those associated, for example, with nervous and immune systems, including health and disorder conditions38.
The findings presented above indicate that prostaglandin tetranor-PGFM as well as HEFAD are related 
directly to SIL conditions in the patients of this study. The literature supports the role of inflammatory pathways 
leading to abnormal production of prostaglandins that can be directly associated with cervical cancer, which is 
coherent for the former lipid39. On the other hand, enhanced lipid peroxidation levels are associated with oxida-
tive injuries and cervical cancer cases when compared to healthy patients40.
Lipids are metabolites that can extremely vary between individuals and in non-disease/disease conditions. 
Furthermore, the plasma samples used in this study have come from women with considerably different lifestyle, 
ages, habits, weights and diseases/medical treatments that are all factors that strongly influence both the lipid 
amount and composition present in the bloodstream. All that information which is not directly related to cervical 
pre-cancerous lesions can be contemplated by the untargeted lipid extraction, adding extra complexity to classify 
NILM and SIL samples. In addition to that, there is an intrinsic source of variation related to SIL class due to the 
existence of two sub-classes LSIL and HSIL among the samples, what can also contribute to enhancing variation 
within SIL class to the detriment of the variation between the classes NILM and SIL, impairing the classification 
performance. Given the complexity observed for the classification based on discriminant analysis models (LDA 
and QDA), a strategy of using a non-linear supervised method was adopted, and for that purpose, the SVM algo-
rithm was applied. SVM is a powerful tool for dealing with biological data since biological processes commonly 
follow a non-linear response25.
SVM-RBF loadings support the chemical meaning of the multivariate statistical model, suggesting that five 
lipids are involved in the spectral changes that allow for differentiation between blood plasma of healthy women 
(NILM) and those suffering from cervical pre-cancerous lesions (SIL). It is worth mentioning that the ability to 
classify NILM and SIL samples with sensitivity and specificity values around 80.0% and 83.3% may represent 
significant clinical interest, since the classification rates obtained by this proposed methodology can be compared 
to those provided by traditional Pap smear test, with the advantage of avoiding the inner subjectivity of the cyto-
logical method.
In conclusion, the results obtained in this study present the potentiality of mass spectrometry associated with 
multivariate analysis as a promising alternative to classifying blood plasma of NILM and SIL women based on 
an untargeted lipidomic approach. The experimental methodology was simple, fast, and with minimal sample 
treatment, being directly injected in the mass spectrometer. Despite the natural complexity of lipids exhibit in 
biological organisms, multivariate analysis was able to extract meaningful information from mass spectrometry 
data allowing to classify the analyzed samples correctly. The best model, PCA-SVM with RBF kernel, achieved 
very satisfactory values of sensitivity (80%) and specificity (83.3%), and a high AUC (0.817) and F-score (0.816) 
indicating its good predictive capacity and accuracy. The utilization of PCA and GA algorithms for data reduc-
tion contributed to simplify the chemical interpretation of results and to speed up computational analysis, since 
a set of 278 m/z features could be reduced to ten principal components or less than twenty selected variables by 
GA. In addition, the predictive performance of SVM models combined with PCA and GA was higher than using 
SVM alone. Some lipid spectral changes were suggested to be contributing to differentiation of samples related to 
NILM and SIL conditions. While PG, GPS and (3′-sulfo)Galβ-Cer are related to NILM class, Tetranor-PGFM and 
HEFAD are directly associated with SIL condition. While these results are encouraging, much larger databases 
of mass spectra of a wider range of medical data, as well as a larger number of blood plasma samples, must be 
established in order to both look for possible biomarkers of cervical pre-cancerous disease and also to study the 
ability of the proposed analysis, based on direct mass spectrometry combined to chemometrics tools, with a view 
to make it possible to properly include this proposed methodology as an efficient alternative in clinical routine 
situations.
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Methods
Collection and preparation of specimens. Women living in the state of Rio Grande do Norte/Brazil 
attending the Maternidade Escola Januário Cicco (MEJC) of the Public Health System for cervical pathology 
screening consultations and reference services for colposcopy were volunteers in this study during July 2014 
to March 2016. The Institutional Ethics Committee for Human Research of the Hospital Universitário Onofre 
Lopes (HUOL), of the Federal University of Rio Grande do Norte (UFRN), Brazil, approved this study (protocol 
#526/11) and informed consent was obtained from all subjects. Also, all the methods carried out in this study 
were by the approved guidelines. A total of 76 blood samples of different women were collected by venipuncture 
in tubes containing the anticoagulant EDTA and within two hours after blood collection plasma was separated 
by density gradient, and aliquots were transferred into cryogenic tubes and stored at −80 °C until analysis. Right 
after blood collection, women were submitted to cytology smears or large loop excision surgery of the transfor-
mation zone (LLETZ). For specimens obtained from LLETZ, histopathological analysis was performed on sec-
tions from paraffin blocks in 4 μm thickness and stained with hematoxylin/eosin. Cytology and histopathology 
were reported according to the Bethesda System41: 42 patients (NILM) and 34 patients (SIL), where 13 are LSIL 
and 31 are HSIL.
Lipid extraction. The Folch method was used for lipid extraction, based upon Patterson et al.42. The plasma 
samples were prepared with one aliquot of 40 µL of blood plasma. Next, 160 µL of methanol was added to samples 
followed by 320 µL of chloroform. Samples were vortexed and incubated on ice for 20 min. Samples were vortexed 
again before the addition of 150 µL of water to induce phase separation and incubation on ice for another 10 min. 
Folch samples were then centrifuged for 5 min at 10,000 rpm. The bottom layer (organic) was removed to a new, 
clean microcentrifuge tube before the top layer was reextracted with 250 µL of chloroform: methanol (2:1, v/v). 
The extraction was vortexed and centrifuged during additional 5 min. Next, the samples were dried. Finally, they 
were reconstituted in 200 µL isopropanol and transferred to vials before MS analysis.
Mass spectrometry conditions. Samples were analyzed in an Electrospray ionization (ESI) coupled to Q 
Exactive Orbitrap mass spectrometer (Thermo Scientific, Bremen, Germany). The mixture was directly infused 
into the ESI source at a flow rate of 5 μL min−1. Mass spectra were recorded in full MS mode ranging from m/z 
200 to 1200 in positive mode. Other experimental parameters used were: spray voltage of 3.0 kV; capillary tem-
perature of 250 °C; S-Lens RF level of 50%; average of 3 micro-scans for each spectrum; and resolution of 140,000. 
The spectra were processed by the Xcalibur Analysis software package (version 2.0, Service Release 2, Thermo 
Electron Corporation).
Identification of lipids. The chemical structures were proposed based on LIPID MAPS® Lipidomic 
Gateway database43 following the way: → ‘Tools’ → ‘Search the LMSD for lipids with a given mass (m/z) value. 
Display structure and isotopic distribution profile’. Errors were provided by Thermo Scientific™ Xcalibur software 
and they were calculated by the difference between the theoretical mass and the experimental mass.
Data analysis and chemometric methods. Computational analysis including import and pre-processing 
of data as well as construction of multivariate classification models (PCA-LDA, PCA-QDA, PCA-SVM, GA-LDA, 
GA-QDA, GA-SVM, KNN and SVM) were performed within MATLAB® R2010a environment (MathWorks Inc, 
Natick, MA, USA) by using PLS Toolbox version 7.9.3 (Eigenvector Research, Inc., USA) and laboratory-made 
routines. Initially, to bunch all spectra into a regular data matrix, i.e. samples in the rows and m/z intensities 
in the columns, it was necessary to create a common vector of m/z values, since each sample had its own mass 
spectrum (with different values of m/z). Thus, a laboratory-made routine was employed to guarantee that all mass 
spectra had the same size, then the data matrix of dimensions 76 × 16540 was built. After that, the matrix was 
normalized so that the sum of squares of each row (sample) was equals to 1. The final pre-processing step was the 
compression (dimensionality reduction) of the data matrix, and for that, it was applied the strategy of selection 
of mass spectrometry regions of interest (ROIs), adapted to analyze only mass spectra (chromatographic free) as 
input data. ROIs allows the selection of m/z values whose intensity signals are higher than a determined threshold 
value (in this case, 3% of the maximum intensity value). A more detailed description of ROIs can be appreciated 
elsewhere44. The compressed matrix, after ROIs selection, was considerably reduced to the dimension of 76 × 278, 
and this matrix was subsequently used as inputs for the classification models.
Before the modeling, samples were divided into training (70%, 54 samples), validation (15%, 11 samples) and 
prediction (15%, 11 samples) sets by the classical Kennard-Stone (KS) algorithm45. Model construction and opti-
mization (variable selection by GA) was carried out using the training samples; and the validation set was applied 
to test its internal performance. The left out samples, the prediction set, were applied to evaluate the classification 
accuracy by LDA, QDA and SVM discrimination approaches. The pre-processed data was applied to the classi-
fication algorithms in two steps: first, data reduction was carried out by PCA or GA; then the scores obtained by 
PCA and the spectral variables selected by GA were utilized as input data for LDA, QDA and SVM classification 
methods. KNN was performed with the whole mass spectra using the validation set to determine the k-value. The 
best result was found with k = 3.
For variable selection using GA, the optimal number of variables was achieved by minimizing the average risk 
of misclassification G, calculated in the validation set as:
∑=
=
G
N
g1
(1)V n
N
n
1
v
where NV is the number of validation samples; and gn is defined as,
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=
≠
G
r x m
r x m
( , )
min ( , ) (2)
n I n
I m I n n I m
2
( )
( ) ( )
2
( )
where I(n) is the index of the true class for the nth validation object xn; r x m( , )n I n
2
( )  is the squared Mahalanobis 
distance between object xn (of class index I(n)) and the sample mean mI(n) of its true class; and r (x , m )
2
n I(m)  is the 
squared Mahalanobis distance between object xn and the center of the closest wrong class46. The minimum value 
of the cost function (maximum fitness) will be achieved when the selected variables from the original data are 
closer as possible to its true class and more distance as possible from its wrong class according to the validation 
samples. GA calculations were performed through 40 generations having 80 chromosomes each. The risk of over-
fitting with GA was reduced by setting the crossover probability to a relatively large number (60%) in order to 
increase the size of the offspring due to the small number of samples; and the mutation probability was set to a 
relatively large value (10%) so the model could adjust to a better fitting throughout mutation. Further, the algo-
rithm was repeated three times, starting from different random initial populations. The best solution (in terms of 
the fitness value) resulting was employed.
LDA classification score (Lik) is calculated for a given class k by the following equation in order to obtain a 
discriminant profile:
L x x x x( ) ( ) 2log (3)ik i k i k e k
T
pooled
1 πΣ= − − −−
where x1 is an unknown measurement vector for sample i; xk is the mean measurement vector of class k; pooledΣ  
is the pooled covariance matrix; and πk is the prior probability of class k47.
QDA classification score (Qik) is estimated using the variance-covariance for each class k and an additional 
natural logarithm term, as follows:
πΣ Σ= − − + −−Q x x x x( ) ( ) log 2log (4)ik i k k i k e k e k
T 1
where Σk is the variance-covariance matrix of class k; and Σloge k  is the natural logarithm of the determinant of 
variance-covariance matrix of class k. QDA forms a separated variance model for each class and does not assume 
classes having similar variance-covariance matrices, differently of what is assumed by LDA48.
SVM classification essentially consists in nonlinearly mapping the original data into a much higher dimen-
sional feature space using a Kernel function, and then constructing an optimal hyperplane that separates objects 
of two classes maximizing the margins of separation49,50. Kernel functions appear in various types (linear, quad-
ratic, polynomial, radial basis function, among others) and their applications change the classification ability of 
SVM25. In this study, different kernel functions were utilized, and they are calculated as follows:
Linear,
k x z x z( , ) (5)i j i j
T=
Quadratic,
τ τ= + ≥( )k x z x z( , ) , 0 (6)i j i jT 2
3rd order polynomial,
( )k x z x z( , ) , 0 (7)i j i jT 3τ τ= + ≥
Radial basis function (RBF),
‖ ‖γ= − −( )k x z x z( , ) exp (8)i j i j2
Multilayer perceptron (MLP),
( )k k kx z x z( , ) tanh (9)i j i j1 T 2= +
where xi and zj are sample measurements vectors; τ is a constant; γ is a tuning parameter that controls the RBF 
width; and k1 and k2 are constants. Finally, the SVM classifier is obtained by the following decision function49,50:
f x yk bx z( ) sign ( , )
(10)i
N
i i i j
1
SV
∑α=



+


=
where NSV is the number of support vectors; αi is the Lagrange multiplier; yi is the class membership (±1); k(x , z )i j  
is the kernel function; and b is the bias parameter.
In the case of clinically classifying non-disease (NILM) and disease (SIL) samples, sensitivity can be under-
stood as the probability that a test result will be positive when the disease is present, while specificity is the 
probability that a test result will be negative when the disease is not present. To statistically evaluate the classi-
fication models, calculations of sensitivity and specificity were performed using the test samples as important 
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quality measures of model accuracy. Both parameters have a maximum value of 100 and a minimum of 0, and are 
obtained as follows:
=
+
×Sensitivity(%) TP
TP FN
100
(11)
=
+
×Specificity(%) TN
TN FP
100
(12)
where FN is defined as a false negative and FP as a false positive; and TP and TN are defined as true positive and 
true negative, respectively.
Also, the models were evaluated using the area under the curve (AUC) and F-score. The AUC is the area under 
the receiver operating characteristics conditions (ROC) curve, and the F-score is a measurement of the model 
accuracy defined by:
− =
× ×
+
F score SENS SPEC
SENS SPEC
2
(13)
where SENS stands for sensitivity; and SPEC stands for specificity.
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